Intralesional sodium stibogluconate under inhaled anesthesia for the treatment of cutaneous leishmaniasis in children: A retrospective cohort

J Am Acad Dermatol. 2019 Oct;81(4):1013-1015. doi: 10.1016/j.jaad.2019.01.083. Epub 2019 Feb 5.

Authors

Yael Renert-Yuval¹, Claes D Enk¹, Sari Murad¹, Valerie Yofe², David Gozal², Vered Molho-Pessach³

Affiliations

¹ Department of Dermatology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
² Division of Anesthesiology and Critical Care Medicine, Hadassah-Hebrew University Medical Center, Jerusalem, Israel.
³ Department of Dermatology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. Electronic address: rverem@hadassah.org.il.

PMID: 30731176
DOI: 10.1016/j.jaad.2019.01.083

No abstract available

Publication types

Letter
Observational Study

MeSH terms

Anesthesia, Inhalation
Antimony Sodium Gluconate / administration & dosage
Antimony Sodium Gluconate / therapeutic use*
Antiprotozoal Agents / administration & dosage
Antiprotozoal Agents / therapeutic use*
Child
Child, Preschool
Female
Humans
Injections, Intralesional
Leishmaniasis, Cutaneous / drug therapy*
Male
Retrospective Studies

Substances

Antiprotozoal Agents
Antimony Sodium Gluconate